Ibrutinib N-1 |
category:Intermediates release date:2021-10-03 |
3-(4-phenoxyphenyl)-1-(3-piperidyl)pyrazolo[3,4-d]pyrimidin-4-amine SPECIFICATION: In-House DOCUMENTATION: Technical package CAS NO. : 1022150-12-4 INDICATION: Ibrutinib N-1 |